BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19337883)

  • 1. Pathophysiology of NSS in ADHD.
    Pasini A; D'agati E
    World J Biol Psychiatry; 2009; 10(4 Pt 2):495-502. PubMed ID: 19337883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
    Emond V; Joyal C; Poissant H
    Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality.
    Zang YF; Jin Z; Weng XC; Zhang L; Zeng YW; Yang L; Wang YF; Seidman LJ; Faraone SV
    Brain Dev; 2005 Dec; 27(8):544-50. PubMed ID: 15876503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and medication effects on rhythmic responses in ADHD: possible oscillatory mechanisms?
    Ben-Pazi H; Shalev RS; Gross-Tsur V; Bergman H
    Neuropsychologia; 2006; 44(3):412-6. PubMed ID: 16083921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate.
    Buchmann J; Gierow W; Weber S; Hoeppner J; Klauer T; Benecke R; Haessler F; Wolters A
    Biol Psychiatry; 2007 Nov; 62(9):963-9. PubMed ID: 17719015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global and regional gray matter reductions in ADHD: a voxel-based morphometric study.
    Carmona S; Vilarroya O; Bielsa A; Trèmols V; Soliva JC; Rovira M; Tomàs J; Raheb C; Gispert JD; Batlle S; Bulbena A
    Neurosci Lett; 2005 Dec; 389(2):88-93. PubMed ID: 16129560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF
    J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attention deficit hyperactivity disorder in adults: a clinical and therapeutic characterization].
    Ramos-Quiroga JA; Bosch-Munsó R; Castells-Cervelló X; Nogueira-Morais M; García-Gimenez E; Casas-Brugué M
    Rev Neurol; 2006 May 16-31; 42(10):600-6. PubMed ID: 16703528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional attentional networks in children with attention deficit/hyperactivity disorder: evidence from an event-related functional magnetic resonance imaging study.
    Konrad K; Neufang S; Hanisch C; Fink GR; Herpertz-Dahlmann B
    Biol Psychiatry; 2006 Apr; 59(7):643-51. PubMed ID: 16197925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour.
    Sagvolden T; Sergeant JA
    Behav Brain Res; 1998 Jul; 94(1):1-10. PubMed ID: 9708834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention deficit/hyperactivity disorder in adults.
    Moss SB; Nair R; Vallarino A; Wang S
    Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter genotype influences the physiological response to medication in ADHD.
    Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
    Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
    Flapper BC; Schoemaker MM
    Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder.
    O'Driscoll GA; Dépatie L; Holahan AL; Savion-Lemieux T; Barr RG; Jolicoeur C; Douglas VI
    Biol Psychiatry; 2005 Jun; 57(11):1452-60. PubMed ID: 15950020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry.
    Teicher MH; Anderson CM; Polcari A; Glod CA; Maas LC; Renshaw PF
    Nat Med; 2000 Apr; 6(4):470-3. PubMed ID: 10742158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit hyperactivity disorder.
    Calis KA; Grothe DR; Elia J
    Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.